Dr. Peter Hotez: ‘The FDA and CDC really had no choice’ but to pause Johnson & Johnson vaccine

Dr. Peter Hotez, co-director of the Texas Children's Hospital Center for Vaccine Development and dean of the National School of Tropical Medicine, joins Ali Velshi to discuss the "pause" on the Johnson & Johnson vaccine in the United States after the discovery of 6 rare cases of blood clotting in women who were immunized with the shot. The goal, says Hotez, is to identify a specific group who might be at higher risk, and that requires a little time. “Even though the U.S. Has other options, man

from MSNBC Top Stories https://ift.tt/3gds4ie
via IFTTT